Risk of diabetes and hypertension in a population with alcohol use disorders.

Alcohol Chronic disorders Diabetes Hypertension Retrospective cohort study

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 Mar 2024
Historique:
received: 06 12 2023
accepted: 10 03 2024
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 22 3 2024
Statut: epublish

Résumé

A population-based follow-up study assessing the risk of developing hypertension and diabetes associated with alcohol use disorder (AUD) is crucial. We investigated this relationship by using insurance claims data from Taiwan. From the claims data, an AUD cohort (N = 60,590) diagnosed between 2000 and 2006 and a non-AUD comparison cohort (N = 60,590) without the diagnosis of hypertension or diabetes at baseline were established and matched by propensity scores estimated by baseline demographic status and the Charlson comorbidity index (CCI). We assessed the incidence rates of hypertension and/or diabetes at the end of 2016 and used Cox's method to estimate the related hazard ratios (HRs) and 95% confidence intervals (CIs). Relative to the comparison cohort, the AUD cohort had an approximately 1.70-fold higher incidence of hypertension (35.1 vs. 20.7 per 1,000 person-years), with an adjusted HR (aHR) of 1.72 (95% CI: 1.68-1.76), 2.16-fold higher incidence of diabetes (20.2 vs. 9.36 per 1,000 person-years), with an aHR of 2.18 (95% CI: 2.11-2.24), and 1.91-fold higher incidence of both diabetes and hypertension (10.3 vs. 5.38 per 1,000 person-years) with an aHR of 2.02 (95% CI: 1.94-2.10). The incidence rates of all outcomes were greater in men than in women, whereas the HRs were greater for AUD in women than for AUD in men relative to the respective comparison patients. The risk increased further for subjects with CCI ≥ 1, which was higher in the AUD cohort. The increased risk of developing diabetes and hypertension in patients with AUD, especially the differences noted according to gender, indicates that clinicians should address potential comorbidities in these patients.

Sections du résumé

BACKGROUND BACKGROUND
A population-based follow-up study assessing the risk of developing hypertension and diabetes associated with alcohol use disorder (AUD) is crucial. We investigated this relationship by using insurance claims data from Taiwan.
METHODS METHODS
From the claims data, an AUD cohort (N = 60,590) diagnosed between 2000 and 2006 and a non-AUD comparison cohort (N = 60,590) without the diagnosis of hypertension or diabetes at baseline were established and matched by propensity scores estimated by baseline demographic status and the Charlson comorbidity index (CCI). We assessed the incidence rates of hypertension and/or diabetes at the end of 2016 and used Cox's method to estimate the related hazard ratios (HRs) and 95% confidence intervals (CIs).
RESULTS RESULTS
Relative to the comparison cohort, the AUD cohort had an approximately 1.70-fold higher incidence of hypertension (35.1 vs. 20.7 per 1,000 person-years), with an adjusted HR (aHR) of 1.72 (95% CI: 1.68-1.76), 2.16-fold higher incidence of diabetes (20.2 vs. 9.36 per 1,000 person-years), with an aHR of 2.18 (95% CI: 2.11-2.24), and 1.91-fold higher incidence of both diabetes and hypertension (10.3 vs. 5.38 per 1,000 person-years) with an aHR of 2.02 (95% CI: 1.94-2.10). The incidence rates of all outcomes were greater in men than in women, whereas the HRs were greater for AUD in women than for AUD in men relative to the respective comparison patients. The risk increased further for subjects with CCI ≥ 1, which was higher in the AUD cohort.
CONCLUSIONS CONCLUSIONS
The increased risk of developing diabetes and hypertension in patients with AUD, especially the differences noted according to gender, indicates that clinicians should address potential comorbidities in these patients.

Identifiants

pubmed: 38515085
doi: 10.1186/s12889-024-18318-y
pii: 10.1186/s12889-024-18318-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

868

Subventions

Organisme : Taiwan Ministry of Health and Welfare Clinical Trial Center
ID : MOHW110-TDU-B-212-124004
Organisme : China Medical University Hospital
ID : DMR-111-228
Organisme : China Medical University Hospital
ID : CMU110-MF-123
Organisme : Ministry of Science and Technology
ID : MOST 110-2321-B-039-003, MOST110-2410-H-039-001 and MOST111-2410-H-039-001-MY2

Informations de copyright

© 2024. The Author(s).

Références

Pastor A, Conn J, MacIsaac RJ, Bonomo Y. Alcohol and illicit drug use in people with diabetes. Lancet Diabetes Endocrinol. 2020;8:239–48.
pubmed: 31958403 doi: 10.1016/S2213-8587(19)30410-3
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
pubmed: 28437734 doi: 10.1016/j.diabres.2017.03.024
Liang Z, Qiu QY, Wu JH, Zhou JW, Xu T, Zhang MZ, et al. Alcohol drinking, dyslipidemia, and diabetes: a population-based prospective cohort study among inner mongolians in China. Biomed Environ Sci. 2016;29:555–62.
pubmed: 27660219
Menke A, Casagrande S, Cowie CC. Cardiometabolic health in asians with diabetes in the US. Diabetes Res Clin Pract. 2017;133:13–9.
pubmed: 28869919 pmcid: 5714299 doi: 10.1016/j.diabres.2017.08.006
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.
pubmed: 32024986 pmcid: 7998524 doi: 10.1038/s41581-019-0244-2
Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
pubmed: 21343206 pmcid: 3043110 doi: 10.1136/bmj.d636
Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38:1804–12.
pubmed: 26294775 doi: 10.2337/dc15-0710
Zilkens RR, Burke V, Hodgson JM, Barden A, Beilin LJ, Puddey IB. Red wine and beer elevate blood pressure in normotensive men. Hypertension. 2005;45:874–9.
pubmed: 15837829 doi: 10.1161/01.HYP.0000164639.83623.76
Peng M, Zhang J, Zeng T, Hu X, Min J, Tian S, et al. Alcohol consumption and diabetes risk in a Chinese population: a mendelian randomization analysis. Addiction. 2019;114:436–49.
pubmed: 30326548 doi: 10.1111/add.14475
McFarlane SI, von Gizycki H, Salifu M, Deshmukh M, Manieram M, Gebreegziabher Y, et al. Alcohol consumption and blood pressure in the adult US population: assessment of gender-related effects. J Hypertens. 2007;25:965–70.
pubmed: 17414659 doi: 10.1097/HJH.0b013e32807fb0ad
Mori TA, Burke V, Beilin LJ, Puddey IB. Randomized controlled intervention of the effects of alcohol on blood pressure in premenopausal women. Hypertension. 2015;66:517–23.
pubmed: 26123682 doi: 10.1161/HYPERTENSIONAHA.115.05773
Steiner JL, Crowell KT, Lang CH. Impact of alcohol on glycemic control and insulin action. Biomolecules. 2015;5:2223–46.
pubmed: 26426068 pmcid: 4693236 doi: 10.3390/biom5042223
Matsumoto C, Miedema MD, Ofman P, Gaziano JM, Sesso HD. An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev. 2014;34:159–71.
pubmed: 24667667 doi: 10.1097/HCR.0000000000000042
Mostofsky E, Mukamal KJ, Giovannucci EL, Stampfer MJ, Rimm EB. Key findings on alcohol consumption and a variety of health outcomes from the nurses’ health study. Am J Public Health. 2016;106:1586–91.
pubmed: 27459455 pmcid: 4981808 doi: 10.2105/AJPH.2016.303336
Minzer S, Losno RA, Casas R. The effect of alcohol on cardiovascular risk factors: is there new information? Nutrients. 2020;12:912.
pubmed: 32230720 pmcid: 7230699 doi: 10.3390/nu12040912
van de Luitgaarden IAT, van Oort S, Bouman EJ, Schoonmade LJ, Schrieks IC, Grobbee DE, et al. Alcohol consumption in relation to cardiovascular diseases and mortality: a systematic review of mendelian randomization studies. Eur J Epidemiol. 2022;37:655–69.
pubmed: 34420153 doi: 10.1007/s10654-021-00799-5
Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105:817–43.
pubmed: 20331573 pmcid: 3306013 doi: 10.1111/j.1360-0443.2010.02899.x
Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of Alcohol Consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
pubmed: 21343207 pmcid: 3043109 doi: 10.1136/bmj.d671
Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015;278:238–50.
pubmed: 26158548 doi: 10.1111/joim.12390
Bell S. Alcohol consumption, hypertension, and cardiovascular health across the life course: there is no such thing as a one-size-fits-all approach. J Am Heart Assoc. 2018;7:e009698.
pubmed: 29950487 pmcid: 6064877 doi: 10.1161/JAHA.118.009698
Kim JH, Lee S, Chow J, Lau J, Tsang A, Choi J, et al. Prevalence and the factors associated with binge drinking, alcohol abuse, and alcohol dependence: a population-based study of Chinese adults in Hong Kong. Alcohol Alcohol. 2008;43:360–70.
pubmed: 18230698 doi: 10.1093/alcalc/agm181
Esser MB, Hedden SL, Kanny D, Brewer RD, Gfroerer JC, et al. Prevalence of alcohol dependence among US adult drinkers, 2009–2011. Prev Chronic Dis. 2014;11:E206.
pubmed: 25412029 pmcid: 4241371 doi: 10.5888/pcd11.140329
Kim SJ, Kim DJ. Alcoholism and diabetes mellitus. Diabetes Metab J. 2012;36:108–15.
pubmed: 22540046 pmcid: 3335891 doi: 10.4093/dmj.2012.36.2.108
Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391:1513–23.
pubmed: 29676281 pmcid: 5899998 doi: 10.1016/S0140-6736(18)30134-X
Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA. 2018;320:815–24.
pubmed: 30167705 pmcid: 7391072 doi: 10.1001/jama.2018.11406
Xu M, Zhou Y, Xu B, Sun J, Wang T, Lu J, et al. Associations of smoking and alcohol consumption with impaired β-cell function in Chinese men. J Diabetes. 2016;8:434–41.
pubmed: 25991060 doi: 10.1111/1753-0407.12314
Choi S, Lee G, Kang J, Park SM, Sung E, Shin HC, et al. Association of change in alcohol consumption on fasting serum glucose, insulin resistance, and beta cell function among Korean men. Alcohol. 2020;85:127–33.
pubmed: 31926928 doi: 10.1016/j.alcohol.2020.01.003
Yang BC, Wu SY, Leung PS. Alcohol ingestion induces pancreatic islet dysfunction and apoptosis via mediation of FGF21 resistance. Ann Transl Med. 2020;8:310.
pubmed: 32355754 pmcid: 7186649 doi: 10.21037/atm.2020.02.129
Husain K, Ansari RA, Ferder L. Alcohol-induced hypertension: mechanism and prevention. World J Cardiol. 2014;6:245–52.
pubmed: 24891935 pmcid: 4038773 doi: 10.4330/wjc.v6.i5.245
Okojie OM, Javed F, Chiwome L, Hamid P. Hypertension and alcohol: a mechanistic approach. Cureus. 2020;12:e10086.
pubmed: 33005509 pmcid: 7522178
Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.
pubmed: 19804464 doi: 10.1111/j.1360-0443.2009.02694.x
Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens. 2012;14:792–8.
doi: 10.1111/jch.12008
Yoo MG, Park KJ, Kim HJ, Jang HB, Lee HJ, Park SI. Association between alcohol intake and incident hypertension in the Korean population. Alcohol. 2019;77:19–25.
pubmed: 30236891 doi: 10.1016/j.alcohol.2018.09.002
Ji A, Lou P, Dong Z, Xu C, Zhang P, Chang G, et al. The prevalence of alcohol dependence and its association with hypertension: a population-based cross-sectional study4 in Xuzhou city, China. BMC Public Health. 2018;18:364.
pubmed: 29548314 pmcid: 5857079 doi: 10.1186/s12889-018-5276-1
Cullmann M, Hilding A, Östenson CG. Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabet Med. 2012;29:441–52.
pubmed: 21916972 doi: 10.1111/j.1464-5491.2011.03450.x
You A. Dietary guidelines for americans. Volume 7. United States Department of Health and Human Services and United States Department of Agriculture; 2015.
Verma S, Hussain ME. Obesity and diabetes: an update. Diabetes Metab Syndr. 2017;11:73–9.
pubmed: 27353549 doi: 10.1016/j.dsx.2016.06.017
Polsky S, Akturk HK. Alcohol consumption, diabetes risk, and cardiovascular disease within diabetes. Curr Diab Rep. 2017;17:136.
pubmed: 29103170 doi: 10.1007/s11892-017-0950-8
Bowman TS, Gaziano JM, Buring JE, Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol. 2007;50:2085–92.
pubmed: 18021879 doi: 10.1016/j.jacc.2007.08.017
Oishi E, Hata J, Honda T, Sakata S, Chen S, Hirakawa Y, et al. Development of a risk prediction model for incident hypertension in Japanese individuals: the Hisayama study. Hypertens Res. 2021;44:1221–9.
pubmed: 34059807 doi: 10.1038/s41440-021-00673-7
Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:958–67.
pubmed: 26388413 pmcid: 4656094 doi: 10.1016/S2213-8587(15)00316-2
Wu CF, Feng NH, Chong IW, Wu KY, Lee CH, Hwang JJ, et al. Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health. 2010;10:1–10.
doi: 10.1186/1471-2458-10-44
van Dam RM. Alcohol consumption and risk of type 2 diabetes in east Asian populations: do healthy patterns of consumption exist? J Epidemiol. 2018;28:106–7.
pubmed: 29093362 pmcid: 5821686 doi: 10.2188/jea.JE20170151

Auteurs

Pei-Ying Tseng (PY)

Department of Public Health, China Medical University, 406, Taichung, Taiwan.
Department of Medicine, Lee's General Hospital, 358, Yuanli, Taiwan.

Fung-Chang Sung (FC)

Management Office for Health Data, China Medical University Hospital, 404, Taichung, Taiwan.
Department of Health Services Administration, China Medical University College of Public Health, 406, Taichung, Taiwan.
Department of Food Nutrition and Health Biotechnology, Asia University, 413, Taichung, Taiwan.

Chih-Hsin Muo (CH)

Management Office for Health Data, China Medical University Hospital, 404, Taichung, Taiwan.

Yu-Ching Lan (YC)

Expert Labs, IBM Taiwan Corporation, 110, Taipei, Taiwan.

Yih-Ing Hser (YI)

Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, 90095, Los Angeles, CA, USA.

Sarina Hui-Lin Chien (SH)

Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

Jong-Yi Wang (JY)

Department of Health Services Administration, China Medical University, 100 Jingmao Rd. Sec. 1, Beitun Dist, 406, Taichung, Taiwan. ericwang@mail.cmu.edu.tw.

Classifications MeSH